CA
NZ
UK
AU
IND
US
Heron Therapeutics, Inc. filed a Form 8-K on November 9, 2026, disclosing that on November 8, 2026, it entered into an Asset Purchase Agreement with CorMedix Inc. to sell substantially all of its assets for a combination of cash, stock, royalties, and potential earn-out …
Joseph Wm. Foran, Chairman and CEO of Matador Resources Co, filed a Form 4 with the SEC on November 9, 2026, disclosing an open-market purchase of 5,000 shares of common stock on November 5, 2026, at a weighted average price of $51.36 per share.
Popular, Inc. filed a Current Report on Form 8-K on November 9, 2026, disclosing a $38 million additional provision for credit losses recognized as a subsequent event in its third-quarter 2026 financial statements, stemming from a quick service restaurant borrower that filed for Chapter …
ADC Therapeutics SA (NYSE:ADCT) reported its third-quarter 2026 financial results on November 9, 2026, disclosing net product revenues of $21.0 million and cash and cash equivalents of $189.2 million as of September 30, 2026, alongside details of a strategic financial restructuring completed in October …
The Goodyear Tire & Rubber Company filed an 8-K on November 9, 2026, announcing that board director Roger Wood has been appointed interim chief executive officer, effective immediately, following the departure of Mark Stewart as CEO, president, and board member.
Inovio Pharmaceuticals, Inc. filed a Form 8-K with the SEC on November 9, 2026, disclosing the pricing and terms of a public offering of common stock and pre-funded warrants expected to generate approximately $80.5 million in net proceeds.
Atea Pharmaceuticals, Inc. filed a Current Report on Form 8-K on November 9, 2026, disclosing that it entered into a Loan and Security Agreement with Hercules Capital, Inc. on November 6, 2026, providing for term loans of up to $200.0 million.
Netcapital Inc. filed a current report on November 9, 2026, disclosing that Nasdaq granted the company an exception period running through February 9, 2027, to file its overdue Annual Report and Quarterly Report after receiving delinquency notifications in August and September 2026.
Ocular Therapeutix, Inc. filed a current report on November 9, 2026, disclosing the election of Riad Sherif, M.D. to its Board of Directors effective November 6, 2026, and the forthcoming resignation of Seung Suh Hong, Ph.D., effective December 31, 2026.
The Goodyear Tire & Rubber Company filed a Form 8-K on November 9, 2026, disclosing that Roger J. Wood was appointed Interim Chief Executive Officer and President effective November 8, 2026, replacing Mark W. Stewart, whose separation was classified as a termination "other than …
Please wait processing your request...